Pharmaceuticals, Biotechnology and Life Sciences
Study showed PNT001 was well-tolerated at dose levels that may provide potential therapeutic effect PNT001 to be evaluated next in…
Study showed PNT001 was well-tolerated at dose levels that may provide potential therapeutic effect PNT001 to be evaluated next in…
Analyst and investor event scheduled for Monday, Feb. 8 at 8:00 a.m. ET Four platform presentations and two posters on…
Analyst and investor event scheduled for Monday, Feb. 8 at 8:00 a.m. ET Four platform presentations and two posters on…
FOSTER CITY, Calif.–(BUSINESS WIRE)–Terns Pharmaceuticals, Inc. (“Terns” or the “Company”), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent…
T3/C15 enriched cannabis fraction inhibits liver fibrosis Findings add to Can-Fite’s expertise and assets in the treatment of liver disease…
Study showed PNT001 was well-tolerated at dose levels that may provide potential therapeutic effect PNT001 to be evaluated next in…
U.S. Food and Drug Administration assigned an action date of May 30, 2021 Supplemental New Drug Application is supported by…
BOSTON & ROCKVILLE, Md.–(BUSINESS WIRE)–Sensei Biotherapeutics, Inc., a clinical-stage immunotherapy company focused on the discovery and development of next generation…
BAUDETTE, Minn.–(BUSINESS WIRE)–ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced the launch of Prazosin HCl Capsules USP,…